Improving Morbidity During Post-Acute Care Transitions for Sepsis
NCT03865602 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 712
Last updated 2022-04-25
Summary
The purpose of this study is to improve transitions of care for the highest risk, complex patients with suspected sepsis. Atrium Health has developed a nurse-navigator facilitated care transition strategy, called the Sepsis Transition and Recovery (STAR) program, to improve the implementation of recommended care practices and bridge care gaps for patients in the post-sepsis transition period. During their hospitalization, STAR program patients enter into a transition pathway facilitated by a centrally located nurse navigator and including the following evidence-based post-sepsis care components: i) review and recommendation for adjustment of medications; ii) identification of and referral for new physical, mental, and cognitive deficits; iii) surveillance for treatable conditions that commonly lead to poor outcomes; and iv) referral to palliative care when appropriate. IMPACTS (Improving Morbidity during Post-Acute Care Transitions for Sepsis) is a pragmatic, randomized program evaluation to compare clinical outcomes between sepsis survivors who receive usual care versus care delivered through the STAR program following hospitalization. IMPACTS will test the hypothesis that patients that receive care through STAR will have decreased composite all cause, 30-day hospital readmission and mortality compared to patients that receive usual care.
Conditions
- Clinical Sepsis
Interventions
- BEHAVIORAL
-
Sepsis Transition And Recovery (STAR)
In the STAR program intervention, a centrally located nurse navigator facilitates the application of four evidence-based core components of post-sepsis care (i.e., review of medications, new impairments, comorbidities, and palliative care) to patients prior to and during the 30 days after hospital discharge. The STAR navigator will provide telephone and EHR-based support within the hospitalization and to patients across all discharge settings with remote monitoring at specified intervals following hospital discharge. Patients will continue to receive STAR directed services for 30 days following their discharge and then will be transitioned back to the next appropriate care location.
- BEHAVIORAL
-
Usual care
Patients and their providers will not have access to the STAR program. Patients will continue to receive usual care throughout their stay and discharge, consisting of: patient education and follow-up instructions at discharge, which are not specific to sepsis; routine recommendations for follow-up visits with primary care providers; arrangements for home health services or care management follow-up based on each patient's needs but not specifically tailored to the sepsis population; discharge to post-acute setting with no sepsis-specific follow-up. All aspects of usual care will be determined by treating clinicians independent of trial assignment.
Sponsors & Collaborators
-
Wake Forest University Health Sciences
lead OTHER
Principal Investigators
-
Marc Kowalkowski, PhD · Wake Forest University Health Sciences
-
Stephanie P Taylor, MD · Wake Forest University Health Sciences
Study Design
- Allocation
- RANDOMIZED
- Purpose
- HEALTH_SERVICES_RESEARCH
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2019-01-29
- Primary Completion
- 2020-12-31
- Completion
- 2021-12-31
Countries
- United States
Study Locations
More Related Trials
-
Beta-lactam Intermittent Versus Continuous Infusion and Combination Antibiotic Therapy in Sepsis
NCT05681442 ·Status: RECRUITING ·Phase: PHASE4
-
Reducing 30-Day Sepsis Readmissions: Impact of a Post Discharge Education Program
NCT05602896 ·Status: WITHDRAWN ·Phase: NA
-
Empiric Antibiotic Treatment for Septic Patients in the Intensive Care Unit
NCT05924126 ·Status: RECRUITING
-
Impact of Aminoglycosides-based Antibiotics Combination and Protective Isolation on Outcomes in Critically-ill Neutropenic Patients With Sepsis: (Combination-Lock01)
NCT05443854 ·Status: UNKNOWN ·Phase: PHASE3
-
Resuscitation Strategies in Septic Shock
NCT02150512 ·Status: UNKNOWN ·Phase: NA
-
Study the Impact of Statins in Septic Shock
NCT02681653 ·Status: COMPLETED ·Phase: NA
-
Implementation and Evaluations of Sepsis Watch
NCT03655626 ·Status: COMPLETED ·Phase: NA
-
Prolonged Intravenous Infusion of β-lactam Antibiotics in Early Septic Patients
NCT05024565 ·Status: UNKNOWN ·Phase: NA
-
Identification and Clinical Efficacy Analysis of Biomarkers in Sepsis Patients
NCT05911711 ·Status: UNKNOWN
-
De-escalation of Empirical Antimicrobial Therapy Study in Severe Sepsis
NCT01626612 ·Status: COMPLETED ·Phase: PHASE3
-
Early Optimization of Ceftazidime Regimen in Critical Care
NCT07085624 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Evaluation in the Treatment of Nosocomial Sepsis Comparing Polymerase Chain Reaction With Conventional Blood Culture.
NCT01450358 ·Status: COMPLETED ·Phase: PHASE4
-
Impact of the Introduction of a Performance Improvement Program on the Initial Management of Sepsis and Septic Shock in Adults in the Emergency Department: a Before-and-after Study (IPA-SOS)
NCT06657625 ·Status: ENROLLING_BY_INVITATION
-
Preemptive Resuscitation for Eradication of Septic Shock
NCT01449721 ·Status: COMPLETED ·Phase: NA
-
Efficacy & Safety of Resatorvid in Adults With Severe Sepsis
NCT00143611 ·Status: COMPLETED ·Phase: PHASE3
-
Assessment of a Proposed Microbiological Alert and Its Impact on a Sepsis Campaign
NCT02325258 ·Status: COMPLETED ·Phase: NA
-
Predict Sepsis; the Predictive Value of Bedside Measures in the Ambulance
NCT03249597 ·Status: COMPLETED
-
Acute Phase Proteins as Early Markers in Sepsis
NCT00641355 ·Status: UNKNOWN
-
Quantification of Dilutional Anemia in the Initial Phase of Sepsis Management: Preliminary Retrospective Study
NCT06242561 ·Status: COMPLETED
-
Comparison of Sepsis Prediction Algorithms
NCT05943938 ·Status: NOT_YET_RECRUITING
-
Sepsis Electronic Prompting for Timely Intervention and Care for Inpatients
NCT06117618 ·Status: COMPLETED ·Phase: NA
-
External Cooling in Septic Shock Patients
NCT00527007 ·Status: COMPLETED ·Phase: NA
-
Statins for the Early Treatment of Sepsis
NCT00528580 ·Status: TERMINATED ·Phase: PHASE2
-
Evaluation of Parameters Collected From Routine Data for the Diagnosis of Sepsis and Septic Shock and Their Influence on Time to Diagnosis and Patient Outcome
NCT05383963 ·Status: RECRUITING
-
Effect of Statin Therapy on Sepsis-related Mortality in Intensive Care Unit Patients
NCT06354452 ·Status: COMPLETED